{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T05:13:34Z","timestamp":1778130814561,"version":"3.51.4"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine if holistic patterns derived from conventional ultrasound features are associated with pathological response to neoadjuvant chemotherapy (NAC) in breast cancer, providing a potential basis for non-invasive treatment monitoring.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study included 509 female breast cancer patients with unilateral primary lesions who underwent NAC followed by surgery. We employed three clustering methodologies to integrate conventional ultrasound features into holistic patterns: the model-based latent class analysis (LCA) and the distance-based K-modes and hierarchical clustering. The association between the resulting patterns and pathological non-response was assessed using Firth logistic regression, with internal validation performed through 10-fold cross-validation and 10, 000 bootstrap resampling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>When comparing the three approaches, LCA was identified as the superior classification framework, providing the best balance of statistical model fit, class separation, and meaningful association with clinical outcomes. The optimal LCA model identified two distinct sonographic patterns, referred to as Pattern A and Pattern B. Pattern B was significantly associated with a 2.51-fold higher (95% CI: 1.05-5.99) likelihood of pathological non-response compared to Pattern A. In subgroup analyses, among defined high-risk groups, Pattern B was linked to an increased risk of pathological non-response ranging from 12.84% (95% CI: 5.74%\u201323.59%) to 21.34% (95% CI: 13.63%\u201328.32%), whereas in non-high-risk groups the corresponding increase ranged from 1.12% (95% CI: 0.79%\u20131.51%) to 3.45% (95% CI: 2.60%\u20134.47%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Patterns of conventional ultrasound features derived through LCA may offer a preliminary indication for identifying breast cancer patients less likely to benefit from NAC, potentially informing more individualized treatment planning following external validation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1813724","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T04:50:37Z","timestamp":1778129437000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Latent class analysis of conventional ultrasound features: a novel approach to predicting non-response to neoadjuvant chemotherapy in breast cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Mei-Lian","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Ultrasound, Fujian Medical University Union Hospital","place":["Fuzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, Fujian Medical University Union Hospital","place":["Fuzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Hua","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Pharmacy Administration, School of Pharmacy, Fujian Medical University","place":["Fuzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Pharmacy Administration, School of Pharmacy, Fujian Medical University","place":["Fuzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing-Qing","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Pharmacy Administration, School of Pharmacy, Fujian Medical University","place":["Fuzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy and Pharmacy Administration, School of Pharmacy, Fujian Medical University","place":["Fuzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Kui","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, Fujian Medical University Union Hospital","place":["Fuzhou, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA: A Cancer J For Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1200\/jco.20.03399","article-title":"Neoadjuvant chemotherapy, endocrine therapy, and targeted therapy for breast cancer: ASCO guideline","volume":"39","author":"Korde","year":"2021","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.5732\/cjc.009.10257","article-title":"Evaluation of the efficacy of neoadjuvant chemotherapy for breast cancer","volume":"14","author":"Wang","year":"2020","journal-title":"Drug Des Dev Ther"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/s0960-9776(19)30256-5","article-title":"Multiparametric MRI-based radiomics analysis for prediction of breast cancers insensitive to neoadjuvant chemotherapy","volume":"22","author":"Xiong","year":"2020","journal-title":"Clin Trans Oncol Off Publ Fed Spanish Oncol Societies Natl Cancer Institute Mexico"},{"key":"B5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41598-020-80415-w","article-title":"Higher efficacy and reduced adverse reactions in neoadjuvant chemotherapy for breast cancer by using pegylated liposomal doxorubicin compared with pirarubicin","volume":"11","author":"Liu","year":"2021","journal-title":"Sci Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1177\/1060028019895783","article-title":"Comparative toxicities of neoadjuvant chemotherapy with or without bevacizumab in HER2-negative breast cancer patients: A meta-analysis","volume":"54","author":"Wang","year":"2020","journal-title":"Ann Pharmacother"},{"key":"B7","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41698-025-01057-7","article-title":"Multimodal prediction based on ultrasound for response to neoadjuvant chemotherapy in triple negative breast cancer","volume":"9","author":"Lyu","year":"2025","journal-title":"NPJ Precis Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105896","article-title":"Deep learning-based prediction of axillary pathological complete response in patients with breast cancer using longitudinal multiregional ultrasound","volume":"119","author":"Liu","year":"2025","journal-title":"EBioMedicine"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.21147\/j.issn.1000-9604.2016.05.02","article-title":"Early prediction of pathological outcomes to neoadjuvant chemotherapy in breast cancer patients using automated breast ultrasound","volume":"28","author":"Wang","year":"2016","journal-title":"Chin J Cancer Res = Chung-Kuo Yen Cheng Yen Chiu"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1102\/1470-7330.2011.9042","article-title":"Contrast-enhanced ultrasound in oncology","author":"Madsen","year":"2011","journal-title":"Cancer Imaging: Off Publ Int Cancer Imaging Soc"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11020081","article-title":"Contrast-enhanced ultrasonography in the diagnosis and treatment modulation of breast cancer","volume":"11","author":"Boca Bene","year":"2021","journal-title":"J Personalized Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2009.12.027","article-title":"Role of color Doppler indices in predicting disease-free survival of breast cancer patients during neoadjuvant chemotherapy","volume":"75","author":"Singh","year":"2010","journal-title":"Eur J Radiol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1159\/000337766","article-title":"Correlation between blood flow signal of color flow imaging and Nottingham prognostic index in patients with breast carcinoma","volume":"7","author":"Shen","year":"2012","journal-title":"Breast Care (Basel Switzerland)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/os.13469","article-title":"A scoring system for predicting neoadjuvant chemotherapy response in primary high-grade bone sarcomas: A multicenter study","volume":"14","author":"He","year":"2022","journal-title":"Orthopaedic Surg"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2014.00029","article-title":"The tumor border configuration of colorectal cancer as a histomorphological prognostic indicator","volume":"4","author":"Koelzer","year":"2014","journal-title":"Front Oncol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.3390\/diagnostics15212718","article-title":"From innovation to application: Can emerging imaging techniques transform breast cancer diagnosis","volume":"15","author":"Hsu","year":"2025"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.3390\/bioengineering11111060","article-title":"Systematic meta-analysis of computer-aided detection of breast cancer using hyperspectral imaging","volume":"11","author":"Leung","year":"2024"},{"key":"B18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.breast.2018.02.028","article-title":"Ultrasound-based prediction of pathologic response to neoadjuvant chemotherapy in breast cancer patients","volume":"39","author":"Baumgartner","year":"2018","journal-title":"Breast (Edinburgh Scotland)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1038\/s41598-021-82141-3","article-title":"Multiparametric ultrasound examination for response assessment in breast cancer patients undergoing neoadjuvant therapy","volume":"11","author":"Dobruch-Sobczak","year":"2021","journal-title":"Sci Rep"},{"key":"B20","doi-asserted-by":"publisher","first-page":"g7594","DOI":"10.1016\/j.eururo.2014.11.025","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"350","author":"Collins","year":"2015","journal-title":"BMJ (Clinical Res Ed)"},{"key":"B21","doi-asserted-by":"crossref","DOI":"10.1002\/9780470567333","volume-title":"Latent class and latent transition analysis: With applications in the social, behavioral, and health sciences","author":"Collins","year":"2009"},{"key":"B22","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1023\/a:1009769707641","article-title":"Extensions to the k-means algorithm for clustering large data sets with categorical values","volume":"2","author":"Huang","year":"1998","journal-title":"Data Min Knowl Discov"},{"key":"B23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.52589\/bjcnit-cv9poogw","article-title":"Overview of agglomerative hierarchical clustering methods","volume":"7","author":"Oti","year":"2024","journal-title":"Br J Computer Networking Inf Technol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/ccm.0000000000004710","article-title":"Practitioner's guide to latent class analysis: Methodological considerations and common pitfalls","volume":"49","author":"Sinha","year":"2021","journal-title":"Crit Care Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13058-021-01447-2","article-title":"Associations of reproductive breast cancer risk factors with breast tissue composition","volume":"23","author":"Yaghjyan","year":"2021","journal-title":"Breast Cancer Research: BCR"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(08)60269-x","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"key":"B27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s12916-023-02950-3","article-title":"Family history and breast cancer risk for Asian women: a systematic review and meta-analysis","volume":"21","author":"Wang","year":"2023","journal-title":"BMC Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"4287","DOI":"10.3390\/cancers13174287","article-title":"Breast cancer-epidemiology, risk factors, classification, prognostic markers, and current treatment strategies-an updated review","volume":"13","author":"\u0141ukasiewicz","year":"2021","journal-title":"Cancers"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-19-3492","article-title":"Pathologic complete response after neoadjuvant chemotherapy and impact on breast cancer recurrence and survival: a comprehensive meta-analysis","volume":"26","author":"Spring","year":"2020","journal-title":"Clin Cancer Research: Off J Am Assoc For Cancer Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ejca.2021.01.028","article-title":"Ultrasound-based deep learning radiomics in the assessment of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer","volume":"147","author":"Jiang","year":"2021","journal-title":"Eur J Cancer (Oxford England: 1990)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.718531","article-title":"Predicting pathological complete response after neoadjuvant chemotherapy in advanced breast cancer by ultrasound and clinicopathological features using a nomogram","volume":"11","author":"Cui","year":"2021","journal-title":"Front Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy127","article-title":"Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis","volume":"29","author":"Poggio","year":"2018","journal-title":"Ann Oncol Off J Eur Soc For Med Oncol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.7150\/jca.24701","article-title":"Significantly higher pathologic complete response (pCR) after the concurrent use of trastuzumab and anthracycline-based neoadjuvant chemotherapy for HER2-positive breast cancer: Evidence from a meta-analysis of randomized controlled trials","volume":"9","author":"Wu","year":"2018","journal-title":"J Cancer"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(13)62422-8","article-title":"Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis","volume":"384","author":"Cortazar","year":"2014","journal-title":"Lancet (London England)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15174336","article-title":"Appraisal of systemic treatment strategies in early HER2-positive breast cancer-a literature review","volume":"15","author":"Giffoni de Mello Morais Mata","year":"2023","journal-title":"Cancers"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14174064","article-title":"Updated neoadjuvant treatment landscape for early triple negative breast cancer: Immunotherapy, potential predictive biomarkers, and novel agents","volume":"14","author":"Garufi","year":"2022","journal-title":"Cancers"},{"key":"B37","doi-asserted-by":"publisher","first-page":"5645","DOI":"10.1038\/s41467-021-26023-2","article-title":"Artificial intelligence system reduces false-positive findings in the interpretation of breast ultrasound exams","volume":"12","author":"Shen","year":"2021","journal-title":"Nat Commun"},{"key":"B38","first-page":"11.20.567934","article-title":"Assessing tumor microenvironment characteristics and stratifying EPR with a nanobubble companion nanoparticle via contrast-enhanced ultrasound imaging","volume-title":"bioRxiv: The Preprint Server for Biology","author":"Cooley","year":"2023"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.943","article-title":"Progress in the clinical detection of heterogeneity in breast cancer","volume":"5","author":"Song","year":"2016","journal-title":"Cancer Med"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1813724\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T04:50:48Z","timestamp":1778129448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1813724\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,7]]},"references-count":39,"alternative-id":["10.3389\/fonc.2026.1813724"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1813724","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,7]]},"article-number":"1813724"}}